Search hospitals > Texas > Houston
Novartis Investigative Site
Claim this profileHouston, Texas 77030
Global Leader in Multiple Sclerosis
Global Leader in Psoriasis
Conducts research for Cancer
Conducts research for Chronic Obstructive Pulmonary Disease
Conducts research for Heart Failure
263 reported clinical trials
6 medical researchers
Summary
Novartis Investigative Site is a medical facility located in Houston, Texas. This center is recognized for care of Multiple Sclerosis, Psoriasis, Cancer, Chronic Obstructive Pulmonary Disease, Heart Failure and other specialties. Novartis Investigative Site is involved with conducting 263 clinical trials across 213 conditions. There are 6 research doctors associated with this hospital, such as Christie Ballantyne, MD, Thomas Howard, Vikram Arora, MD, and Mehrdad Ariani.Top PIs
Christie Ballantyne, MDBaylor College of Medicine3 years of reported clinical research
Studies Dyslipidemia
Studies Dyslipidemias
5 reported clinical trials
4 drugs studied
Thomas HowardUniversity of Alabama 1600 7th ave3 years of reported clinical research
Studies Sickle Cell Disease
Studies Sickle Cell Anemia
3 reported clinical trials
3 drugs studied
Vikram Arora, MDGrandview Health/Alabama Cardiovascular Group4 years of reported clinical research
Studies Cardiovascular Disease
Studies Diabetes
3 reported clinical trials
3 drugs studied
Mehrdad ArianiValley Clinical Trials, Inc.3 years of reported clinical research
Studies Heart Failure
Studies Cardiovascular Disease
4 reported clinical trials
5 drugs studied
Clinical Trials running at Novartis Investigative Site
Multiple Sclerosis
Giant Cell Arteritis
Sickle Cell Anemia
Sickle Cell Disease
Allergy
Food Allergy
Coronary Artery Disease
Cardiovascular Disease
Chronic Urticaria
Peanut Allergy
Ofatumumab
for Multiple Sclerosis
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofatumumab versus staying on their continued current therapy. This study will also look at whether an elevated serum neurofilament light (NfL) level predicts enhanced benefit from a switch to ofatumumab.
Recruiting3 awards Phase 410 criteria
Ofatumumab
for Multiple Sclerosis
Recruiting2 awards Phase 3
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in Houston, Texas. This center is recognized for care of Multiple Sclerosis, Psoriasis, Cancer, Chronic Obstructive Pulmonary Disease, Heart Failure and other specialties. Novartis Investigative Site is involved with conducting 263 clinical trials across 213 conditions. There are 6 research doctors associated with this hospital, such as Christie Ballantyne, MD, Thomas Howard, Vikram Arora, MD, and Mehrdad Ariani.